bpc-157 human clinical trial osteoarthritis BPC-157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven Overall, 14 of 16 patients

The BNF recently (2019) changed its guidance for the frequency of injections of hydroxocobalamin: Every 2 months in patients who have neurological symptoms Every 2 or 3 months when there are no neurological symptoms

If B12 deficiency is clinically suspected, IM hydroxocobalamin should be started promptly without waiting for blood test results

If you want dramatic weight loss, AOD-9604 is not the compound

Patients are typically pre-medicated with folic acid, vitamin B12, and a corticosteroid (like dexamethasone) to help reduce the incidence and severity of some of these side effects, particularly skin reactions and bone marrow suppression

doi: 10.1002/lary.22490

TB-500 What is the main difference between BPC-157 and TB-500